Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Journal of Internal Medicine|May 1, 1991
Characteristics of patients resistant to antihypertensive drug therapyH Isaksson, M Danielsson, G Rosenhamer, et al.Journal of Clinical Pharmacology|February 1, 1990
Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenololE Dimenäs, J Ostergren, K Lindvall, et al.Diabetologia|December 1, 1996
Altered properties of the fibrin gel structure in patients with IDDMG Jörneskog, N Egberg, B Fagrell, et al.Thrombosis Research|September 15, 1982
Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosisG Andersson, B Fagrell, K Holmgren, et al.European Heart Journal|December 20, 2003
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial diseaseJ Ostergren, P Sleight, G Dagenais, et al.Journal of Internal Medicine|May 4, 2010
Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and womenM J Holzmann, T Ivert, I Jungner, et al.Transfusion Medicine (Oxford, England)|February 19, 2008
A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesiaC Olofsson, E B Nygårds, S Ponzer, et al.Journal of Cardiac Failure|September 25, 1999
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme InvestigatorsK Swedberg, M Pfeffer, C Granger, et al.European Journal of Heart Failure|June 12, 2003
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programmeJ McMurray, J Ostergren, M Pfeffer, et al.Journal of Hypertension|June 14, 2001
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsP S Sever, B Dahlöf, N R Poulter, et al.Pageof 12